Genialis and Inventia to enhance pancreatic cancer treatment testing
The companies will combine Genialis Supermodel with Inventia’s RASTRUM 3D model platform to study PDAC.
Drug Development
Basecamp Research secures $140m for AI-driven therapies
BoomRay and Novartis sign $900m deal for radioligand therapy
Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal
Made Scientific acquires cell therapy facility in Pennsylvania, US
EC approves Menarini and NewAmsterdam’s obicetrapib therapies
Telix to acquire ITM in deal worth up to $2.35bn
Sandoz and mAbxience agree on emicizumab biosimilar partnership
